Fred Hutchinson Cancer Center is an independent, nonprofit organization providing adult cancer treatment and groundbreaking research focused on cancer and infectious diseases. Based in Seattle, Fred Hutch is the only National Cancer Institute-designated cancer center in Washington.
With a track record of global leadership in bone marrow transplantation, HIV/AIDS prevention, immunotherapy and COVID-19 vaccines, Fred Hutch has earned a reputation as one of the world’s leading cancer, infectious disease and biomedical research centers. Fred Hutch operates eight clinical care sites that provide medical oncology, infusion, radiation, proton therapy and related services, and network affiliations with hospitals in five states. Together, our fully integrated research and clinical care teams seek to discover new cures to the world’s deadliest diseases and make life beyond cancer a reality.
At Fred Hutch we value collaboration, compassion, determination, excellence, innovation, integrity and respect. These values are grounded in and expressed through the principles of diversity, equity and inclusion. Our mission is directly tied to the humanity, dignity and inherent value of each employee, patient, community member and supporter. Our commitment to learning across our differences and similarities make us stronger. We seek employees who bring different and innovative ways of seeing the world and solving problems. Fred Hutch is in pursuit of becoming an anti-racist organization. We are committed to ensuring that all candidates hired share our commitment to diversity, anti-racism and inclusion.
The Talbot lab, within the Basic Science Division at Fred Hutchinson Cancer Center, is recruiting a highly motivated postdoctoral fellow to lead cutting-edge studies to understand the neural basis of intestinal regulation of immunity and metabolism.
The Talbot lab studies the gut-brain axis, and how gut neurons sense diet and microbes, regulating immunity, metabolism, and nutrition. For that, we use mouse models, intravital imaging, calcium reporters, molecular immunology, viral-assisted neural circuit tracing, optogenetics and chemogenetics, CRISPR-Cas9 genetic alterations, single-cell genomics, and diet engineering. One objective of our studies is to develop dietary strategies that use the modulation of gut neurons to combat gastrointestinal-associated diseases, including inflammatory bowel disease, irritable bowel syndrome, gut infections, malabsorption conditions, and metabolic disturbances. This research offers the opportunity to study the intersection of different areas including neurobiology, immunology, host-microbiota interactions, nutrition, and gastroenterology.
More information: https://www.jhimmylab.org/
The successful candidate will have the ability to work both independently and in a highly collaborative environment.
The fellow will be responsible for developing and executing a project related to the interests of the lab. Namely, investigating the role of neuroimmune interactions in intestinal homeostasis using a mouse model system. Potential research topics include to investigate:
The ideal candidate will be: (i) interested and able to develop their own research strategy to answer questions utilizing an array of innovative mouse models and sophisticated approaches that we have developed in the lab, and (ii) expected to contribute to a creative, collaborative and bustling laboratory environment.
Fred Hutchinson Cancer Center has a mandatory COVID-19 vaccine requirement, with exceptions only for approved medical or religious accommodations. As a condition of employment, newly hired employees must, prior to their first day of employment:
Provide proof of being fully vaccinated against COVID-19 ; OR
Initiate the accommodations process to request a religious or medical accommodation (medical accommodations require a healthcare provider’s certification).
A statement describing your commitment and contributions toward greater diversity, equity, inclusion, and antiracism in your career or that will be made through your work at Fred Hutch is requested of all finalists.